Active specific immunotherapy as an adjunct to the treatment of metastatic solid tumors: present and future prospects.

Key ME, Hoover HC Jr, Hanna MG Jr

Open source

DOI
10.1007/978-1-4612-5068-5_6
Published
1985
Container
Advances in immunity and cancer therapy
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/978-1-4612-5068-5_6,
  title = {Active specific immunotherapy as an adjunct to the treatment of metastatic solid tumors: present and future prospects.},
  author = {Key ME and Hoover HC Jr and Hanna MG Jr},
  year = {1985},
  journal = {Advances in immunity and cancer therapy},
  doi = {10.1007/978-1-4612-5068-5_6},
  url = {https://doi.org/10.1007/978-1-4612-5068-5_6}
}

RIS

TY  - JOUR
TI  - Active specific immunotherapy as an adjunct to the treatment of metastatic solid tumors: present and future prospects.
AU  - Key ME
AU  - Hoover HC Jr
AU  - Hanna MG Jr
PY  - 1985
JO  - Advances in immunity and cancer therapy
DO  - 10.1007/978-1-4612-5068-5_6
UR  - https://doi.org/10.1007/978-1-4612-5068-5_6
ER  - 

APA

ME, K., Jr, H. H., & Jr, H. M. (1985). Active specific immunotherapy as an adjunct to the treatment of metastatic solid tumors: present and future prospects.. Advances in immunity and cancer therapy. https://doi.org/10.1007/978-1-4612-5068-5_6

Source records